A new telephone-based program implemented in a Federally Qualified Health Center (FQHC) demonstrates effectiveness in ...

When managing complex chronic dermatologic diseases, efforts to incorporate alternative treatments can add efficacy, patient ...

The US Food and Drug Administration (FDA) has approved nemolizumab for moderate-to-severe atopic dermatitis inadequately ...

The prevalence of multiple psychiatric comorbidities is significantly higher in people with epilepsy than in those without ...

Intensive follow-up testing in patients with stage II or III CRC following curative surgery does not appear to improve 10-year overall or colorectal cancer–specific mortality rates.

InterRhythmic care may help improve depressive and anxiety symptoms, interpersonal problems, and social function in patients with major depressive disorder.

Wound healing is a core skill in dermatology, but true expertise involves incorporating new techniques with medical school basics to address challenging cases.

Paxneury and Tuzulby should be granted Europe-wide marketing authorizations for treating attention-deficit hyperactivity, the ...

The European Medicines Agency (EMA) has given a positive recommendation for Rytelo ( imetelstat) for the treatment of adult ...

Europe’s medicines regulator has backed a pediatric indication for Ofev to treat progressive fibrosing interstitial lung ...

Allan-Herndon-Dudley syndrome is caused by mutations in the gene coding for a thyroid hormone transporter, preventing thyroid hormones from entering brain cells.

The EMA’s Committee for Medicinal Products for Human Use (CHMP) determined that expected clinical benefits of seladelpar include delayed development of liver fibrosis and cirrhosis, potentially ...